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STUDY QUESTIONS:We aim to produce, disseminate and implement a core outcome set for future infertility research.
WHAT IS KNOWN ALREADY: Randomized controlled trials (RCTs) evaluating infertility treatments have reported many different out-
comes, which are often deﬁned and measured in different ways. Such variation contributes to an inability to compare, contrast and combine
results of individual RCTs. The development of a core outcome set will ensure outcomes important to key stakeholders are consistently col-
lected and reported across future infertility research.
STUDY DESIGN, SIZE, DURATION: This is a consensus study using the modiﬁed Delphi method. All stakeholders, including healthcare
professionals, allied healthcare professionals, researchers and people with lived experience of infertility will be invited to participate.
PARTICIPANTS/MATERIALS, SETTING, METHODS: An international steering group, including people with lived experience of infer-
tility, healthcare professionals, allied healthcare professionals and researchers, has been formed to guide the development of this core outcome
set. Potential core outcomes have been identiﬁed through a comprehensive literature review of RCTs evaluating treatments for infertility and
will be entered into a modiﬁed Delphi method. Participants will be asked to score potential core outcomes on a nine-point Likert scale anchored
between one (not important) and nine (critical). Repeated reﬂection and rescoring should promote convergence towards consensus ‘core’ out-
comes. We will establish standardized deﬁnitions and recommend high-quality measurement instruments for individual core outcomes.
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Introduction
Infertility is a disease of the reproductive system deﬁned by the failure
to achieve a clinical pregnancy following 12 months or more of regular
unprotected sexual intercourse (Zegers-Hochschild et al., 2009). It is
estimated that infertility affects one in six couples (Thoma et al., 2013).
The main categories of infertility include ovulatory disorders, tubal
damage, uterine or peritoneal disorders, reduced semen quantity and
quality, and unexplained infertility (Collins and van Steirteghem, 2004).
Treatment falls into two main categories: interventions to restore fer-
tility when a clear cause is established, such as ovulation induction, and
assisted reproductive technology (ART). Potential infertility treatments
require careful evaluation.
Randomized controlled trials (RCTs), where the inclusion criteria
are broad, and the outcomes are patient-centred, are the best way of
establishing the comparative efﬁcacy and safety of treatments. While
individual RCTs are useful, pooling results from all available RCTs is
likely to provide the best evidence to inform clinical practice (Duffy
et al., 2017a). Considerable attention has been paid to standardizing
the methods of conducting RCTs and systematic reviews. However,
the selection, collection and reporting of outcomes has been largely
overlooked and there is currently limited consensus regarding the out-
comes and outcome measures infertility research should collect and
report (Duffy et al., 2017c).
In the absence of a standardized approach, researchers have made
arbitrary decisions, and this has resulted in many different outcomes
and outcome measures collected and reported in infertility RCTs
(Dapuzzo et al., 2011; Braakhekke et al., 2014; Wilkinson et al., 2016).
A recent systematic review of 910 RCTs evaluating fertility treatments
identiﬁed that only a ﬁfth of included trials reported live birth (182/
910; 20%). Singleton live birth was the primary outcome in 68 trials
(7.4%). Only a minority of included trials reported maternal outcomes
(52/910; 5.7%) and neonatal outcomes (44/910; 4.8%) (Braakhekke
et al., 2014). Adverse outcomes, including ovarian hyperstimulation
syndrome, congenital anomalies and long-term health risks, were infre-
quently reported (Braakhekke et al., 2015). The complexity of the situ-
ation is further increased because individual numerators can be
associated with numerous different denominators: for example, a
recent review of infertility RCTs identiﬁed 15 different denominators
for clinical pregnancy (Wilkinson et al., 2017).
The lack of consensus regarding the collection and reporting of out-
comes limits the comparison and pooling of individual trial data and
directly impacts the usefulness of research to inform patients and pro-
fessionals in clinical practice. Such diversity of outcome collection and
reporting has been demonstrated in many different reproductive con-
ditions, including endometriosis, pre-eclampsia and preterm birth
(Hirsch et al., 2016; Duffy et al., 2017b, 2017c, 2017d; van’t Hooft
et al., 2016).
With so many different outcomes and outcome measures in com-
mon use, there is considerable scope for selective emphasis and report-
ing of results. Outcome reporting bias is deﬁned as the selection for
publication of a subset of the original recorded outcome variables on
the basis of the results (Kirkham et al., 2010). Several systematic reviews
evaluating interventions for infertility have reported the possibility of
outcome reporting bias (Duffy et al., 2009, 2010, 2014). Several studies
have conﬁrmed outcome reporting bias and quantiﬁed its impact when
pooling data from individual RCTs in a meta-analysis (Chan et al., 2004;
Chan and Altman, 2005; Kirkham et al., 2010; Smyth et al., 2011; Hart
et al., 2012; Page et al., 2014; Saini et al., 2014). A systematic review of
157 Cochrane systematic reviews, published in 2007, revealed that
over a third had at least one randomized trial at high risk of outcome
reporting bias (Kirkham et al., 2010). A sensitivity analysis, excluding
those with reporting bias, demonstrated a relative reduction of over
20% in the treatment effect of the primary outcome (Clark et al., 1998).
The research community has engaged with the process of standard-
izing the reporting of RCTs of infertility treatments. An international
WHATDOES THIS MEAN FOR PATIENTS?
Research studies testing new treatments for infertility often measure different outcomes.
Some use pregnancy as their mark of success, while others count live births, and they may, or may not, collect information about risks or side effects.
When complete, the results from different research studies cannot be easily compared or combined, to see which treatments work best. This is a bar-
rier to improving the care people with infertility receive.
The article explains that an international group of healthcare professionals, researchers and fertility patients has been set up to overcome this
barrier by developing a core set of outcomes that would be common to all future infertility research. They started by collecting all the different
outcomes currently reported by infertility research and will go on to ask healthcare professionals, allied healthcare professionals, researchers
and fertility patients what outcomes they think are important in a three-round questionnaire. Anyone, anywhere can participate. The results will
be used to select the most meaningful outcomes which will consistently be collected and reported in future infertility research.
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working group established a consensus process to modify the
Consolidated Standards of Reporting Trials (CONSORT) statement.
The improving the reporting of RCTs of infertility treatments
(IMPRINT) statement made several recommendations including a pre-
ferred primary outcome for all infertility RCTs of live birth, deﬁned as
delivery of a live infant >20 weeks gestation, or cumulative live birth,
deﬁned as where more than one cycle occurs or where frozen
embryos are transferred (Legro et al., 2014).
The next challenge is to address the unwarranted variation in out-
come collection and reporting (Dapuzzo et al., 2011; Braakhekke et al.,
2014; Wilkinson et al., 2016). The development and implementation of
a minimum data set, termed a core outcome set, would help to address
these issues. Core outcome sets are minimum collections of outcomes
with standardized measurement and reporting (Williamson et al., 2012).
They are identiﬁed using consensus science methods, thereby enabling
key stakeholders, including healthcare professionals, researchers and
patients, to suggest and prioritize outcomes (Duffy et al., 2017e).
We aim to produce, disseminate and implement a core outcome set
for infertility RCTs, systematic reviews and clinical practice guidelines.
Materials andMethods
Prospective registration
This study has been prospectively registered with the Core Outcome
Measures in Effectiveness Trials (COMET) initiative; the registration num-
ber is 1023 and is available online (www.comet-initiative.org/studies/
details/1023).
Steering group
An international steering group, including people with lived experience of
infertility, healthcare professionals and researchers, has been formed to guide
the development of this core outcome set (Fig. 1). Members of the steering
group represent various disciplines, geographical areas and expertise.
Core outcome set scope
The steering group recommend the core outcome set should apply to
RCTs, systematic reviews and clinical practice guidelines evaluating inter-
ventions to restore or circumvent infertility.
The study’s methods have been informed by reviewing previous core
outcome sets in women’s and newborn health (Duffy et al., 2016a; Hirsch
et al., 2016b; Khalil et al., 2017; Webbe et al., 2017; Whitehouse et al.,
2017).
Stage 1: Identifying potential core outcomes
We have performed a systematic review of infertility RCTs and extracted
the reported outcomes and outcome measures (Wilkinson et al., 2016). A
comprehensive inventory of outcomes will be developed in consultation
with key stakeholders including healthcare professionals, researchers and
people with lived experience of infertility (Duffy and McManus, 2016b).
During the iterative development of the inventory of outcomes, consider-
ation will be given to efﬁcacy and safety outcomes, the aim of the interven-
tion, for example, interventions aiming to circumvent infertility, and the
timing of the intervention, for example, preconception interventions. Lay
deﬁnitions will be developed for individual outcomes. The outcome inven-
tory and lay deﬁnitions will be entered into a modiﬁed Delphi method.
Stage 2: Identifying core outcomes
The modiﬁed Delphi method assesses the extent of agreement and then
resolves disagreement (Sinha et al., 2011). The survey will be piloted to
ensure the ease of completion. Stakeholders including healthcare profes-
sionals, researchers and people with lived experience of infertility, will be
invited to participate. There is no robust method for calculating the
required sample size. We aim to recruit a minimum of 16 participants for
each stakeholder group.
During round one, participants will provide their demographic details
and will be allocated a unique identiﬁer, which facilitates future anonymity.
Potential core outcomes will be presented within each domain and partici-
pants will be asked to score individual outcomes using a nine-point scale
from one (not important for decision making) to nine (critical for decision
making) (Guyatt et al., 2011). Participants will be invited to suggest add-
itional outcomes before completing the ﬁrst-round survey.
All outcomes will be carried forward from round one into round two.
For each outcome, the percentage of participants scoring individual out-
comes during round one at each possible response from one to nine will
be calculated and tabulated for their own stakeholder group. Additional
outcomes will be considered by the steering group, prompting the refor-
mulation of round one outcomes and the inclusion of additional outcomes
in round two.
During the round two survey, participants will receive their own scores
and stakeholder group feedback for each round one outcome. Participants
will be invited to reﬂect upon summarized stakeholder group feedback and
their own score before rescoring round one outcomes as well as scoring
additional outcomes suggested by participants in round one.
All outcomes will be carried forward from round two into round
three. For each outcome, the percentage of participants scoring individ-
ual outcomes during round two at each possible response from one to
nine will be calculated and tabulated for each individual stakeholder
group. During the round three survey, participants will receive their
own scores and stakeholder group feedback for each round two out-
come. Participants will be invited to reﬂect upon summarized stake-
holder group feedback and their own score before rescoring round two
outcomes.
Following round three, a standardized deﬁnition will be applied to the
results to identify prioritized outcomes, deﬁned by a median score of eight
in each stakeholder group. A consensus development workshop will
review the round three results. The objective of the consensus workshop
will be to develop a ﬁnal core outcome set for infertility.
Stage 1 Identifying Potential Outcomes
Stage 2 Determining Core Outcomes
Stage 3 Determining How Core Outcomes Should Be Measured
Systematic Review What outcomes have been reported before?
Modified Delphi Method Combining the views of stakeholders
Quality Assessment Ensuring outcome measures fit for purpose
Stakeholder Consultation Final consensus
Core Outcomes Set for Infertility
Consensus meeting Stakeholder consultation
Figure 1 Developing a core outcome set for infertility trials.
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Stage 3: Identifying and standardizing core
outcomemeasures
Once core outcomes are agreed upon, we will determine how the out-
comes should be deﬁned and measured. Potential deﬁnitions will be inven-
toried across formal deﬁnition development initiatives, national and
international guidelines, Cochrane systematic reviews and RCTs (Fig. 2).
Potential deﬁnitions will be entered into a consensus development work-
shop including healthcare professionals, researchers and people with lived
experience of infertility. The objective of the consensus workshop will be
to identify deﬁnitions for individual core outcomes. Careful attention will
be paid to the appropriate selection of both numerators and denomina-
tors. Potential measurement instruments will be inventoried across
national and international guidelines, Cochrane systematic reviews and
RCTs. Potential measurement instruments will be quality assessed using
the COMET initiative and the Consensus-Based Standards for the
Selection of Health Measurement Instruments (COSMIN) initiative quality
assessment framework (Prinsen et al., 2016). High-quality measurement
instruments will be associated with core outcomes.
Ethical review
We asked the advice of the National Research Ethics Service about
whether this study required ethical review by an NHS Research Ethics
Committee, and they advised that this study should be considered as ser-
vice evaluation and development, and therefore not require ethical review.
Discussion
Implementing core outcome sets in future RCTs, systematic reviews
and clinical guidelines could reduce research waste and advance the
relevance of research to inform clinical practice.
Improving outcome selection
The Standard Protocol Items: Recommendations for Interventional
Trials (SPIRIT) statement, implemented by funders of health research
including the National Institutes of Health, European Commission,
and the National Institute of Health Research, recommend the use of
core outcome sets where they exist. A core outcome set ensures
that outcomes relevant to all stakeholders, including healthcare pro-
fessionals, researchers and patients, are collected and reported
(Duffy et al., 2017e).
Improving outcome reporting
The Core Outcomes in Women’s and Newborn Health (CROWN) ini-
tiative, a consortium of 84 speciality journals, including the Cochrane
Gynaecology and Fertility Group, Human Reproduction and Human
Reproduction Update has been established to support the develop-
ment, dissemination, and implementation of core outcome sets (Khan,
2014; Duffy et al., 2017e). Participating journals will require researchers
to report core outcomes and outcome measures (Khan, 2014).
Infrastructure to support future research
Developing a core outcome set will establish an international network
of organizations and stakeholders with experience of contributing to a
collaborative consensus study. This infrastructure could be leveraged
in other settings, for example, prioritizing research uncertainties.
Conclusion
Rigorous implementation of a core outcome set should ensure that
outcomes important to all stakeholders, including healthcare profes-
sionals, researchers and people with infertility, will be collected and
reported in a standardized fashion, advancing the usefulness of
research to inform clinical practice.
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